Delveinsight Business Research Group
Generated 5/24/2026
Executive Summary
DelveInsight Business Research Group is a leading Indian market research and consulting firm specializing in pharma, biotech, and medtech intelligence. Founded in 2014, the company leverages AI-driven epidemiology platforms and a repository of over 7,000 reports to provide data-rich forecasts, KOL profiling, and competitive analysis across 27 therapeutic areas. Serving a global clientele of pharma and biotech companies, it supports pipeline, launch, and commercial strategies with customized insights. DelveInsight has established itself as a trusted partner in the life sciences intelligence space, with a strong foothold in oncology, rare diseases, and neurology. Its platform-based business model and continuous investment in AI and data analytics position it well to capture growing demand for evidence-based market intelligence. With an estimated 200-500 employees and a private funding structure, the company is poised for sustained growth as the life sciences sector increasingly relies on data-driven decision-making. DelveInsight's ability to integrate real-world evidence with predictive modeling offers a competitive edge in an expanding market.
Upcoming Catalysts (preview)
- Q1 2027Launch of Next-Gen AI Epidemiology Platform80% success
- Q2 2027Expansion into Gene Therapy and Cell Therapy Market Intelligence70% success
- Q3 2026Strategic Partnership with Top-20 Pharma for Custom Analytics Suite60% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)